Loading…
Inhibition of autoimmune diabetes in NOD mice with serum from streptococcal preparation (OK‐432)‐injected mice
SUMMARY We have recently reported that systemic and chronic administration of recombinant tumour necrosis factor alpha (TNF‐α), as well as streptococcal preparation (OK‐432), inhibits development of insulin‐dependent diabetes mellitus (IDDM) in NOD mice and BB rats, models of IDDM. In this study we...
Saved in:
Published in: | Clinical and experimental immunology 1991-12, Vol.86 (3), p.413-418 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | SUMMARY
We have recently reported that systemic and chronic administration of recombinant tumour necrosis factor alpha (TNF‐α), as well as streptococcal preparation (OK‐432), inhibits development of insulin‐dependent diabetes mellitus (IDDM) in NOD mice and BB rats, models of IDDM. In this study we examined whether serum containing endogenous TNF induced by OK‐432 injection could inhibit IDDM in NOD mice. Treatment twice a week from 4 weeks of age with OK‐432‐injected mouse serum, which contained endogenous TNF (75U), but not IL‐1, IL‐2 and interferon‐gamma (IFN‐γ) activity, reduced the intensity of insulitis and significantly inhibited the cumulative incidence of diabetes by 28 weeks of age in NOD mice, as compared with the incidence in non‐treated mice (P |
---|---|
ISSN: | 0009-9104 1365-2249 |
DOI: | 10.1111/j.1365-2249.1991.tb02946.x |